Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yantai Zhenghai Bio-Tech has several commercialized regenerative medical materials including oral cavity repair membranes ("Heal-All"), absorbable dural patches for neurosurgical use, skin repair films ("Heal-Full"), bone graft materials containing recombinant human BMP‑2 with collagen scaffolds ("active biological bone"), surgical caulking sponges, and self‑etching adhesives. Their pipeline includes new biomaterials such as calcium-silicate bioceramic bone repair material currently at the registration stage. The company’s core decellularization technology underpins its marketed portfolio. Clinical results support widespread adoption across dental/oral surgery, neurosurgery, ENT and wound care specialties throughout China.[1][4][5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yantai Zhenghai Bio-Tech.